Aprea Therapeutics (APRE) Return on Assets [ROA] (2023 - 2026)
Aprea Therapeutics' Return on Assets [ROA] was -29.42% in Q2 2026, up 49.43 percentage points from -78.85% a year earlier and up 10.17 percentage points from the prior quarter.
Powered by 
Analysis
Aprea Therapeutics (APRE) Return on Assets [ROA] (2023 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Aprea Therapeutics came in at -66.31%, down 4.89 percentage points from FY2024.
- Return on Assets [ROA] shows a four-year change of -16.26 percentage points (FY2021 to FY2025).
- In earlier years, Return on Assets [ROA] was -61.42% in FY2024 (-2.82 pp), -58.60% in FY2023 (+202.13 pp), -260.73% in FY2022 (-210.68 pp) and -50.05% in FY2021.
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] in data going back to Q1 2023.
- Compared with a year earlier, Return on Assets [ROA] was higher in four of the last eight quarters, with an average year-over-year change of -3.97 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2024 (a gain of 303.51 percentage points); the worst was Q3 2025 (a drop of 35.41 percentage points).
- Per Business Quant data, APRE's Return on Assets [ROA] in the three quarters before Q2 2026 was -39.59% (Q1 2026), -87.48% (Q4 2025) and -87.36% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Aprea Therapeutics | 37.44 Mn | 37.44 Mn | - | -29.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.42% |
| Mar 31, 2026 | -39.59% |
| Dec 31, 2025 | -87.48% |
| Sep 30, 2025 | -87.36% |
| Jun 30, 2025 | -78.85% |
| Mar 31, 2025 | -69.03% |
| Dec 31, 2024 | -56.30% |
| Sep 30, 2024 | -51.95% |
| Jun 30, 2024 | -44.94% |
| Mar 31, 2024 | -50.13% |
| Dec 31, 2023 | -63.91% |
| Sep 30, 2023 | -53.07% |
| Jun 30, 2023 | -49.84% |
| Mar 31, 2023 | -353.64% |
API Access
Aprea Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=APRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "APRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=APRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();